Literature DB >> 17593336

[Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].

T Jäger1, T Szarvas, F vom Dorp, C Börgermann, M Schenck, K W Schmid, H Rübben.   

Abstract

The protein structure of human tumor tissue has a significant influence on the molecular attributes. It was demonstrated that the individual prognosis of tumor patients is among other things dependent on molecular tumor tissue characteristics.A promising marker is E-cadherin, an adhesion glycoprotein which plays a central role in the mediation of cell-cell contacts. Aberrant E-cadherin expressions were described in several tumors such as in bladder cancer. This was also found to be correlated with tumor invasion and survival. There are hardly any fast, quantitative and easily automated protein assays in everyday practice which can analyze several markers at the same time. With silicon chip technology we have a new detection and measurement method which makes it possible to give a quantitative analysis of numerous different proteins in tissue, urine, or serum in a few minutes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593336     DOI: 10.1007/s00120-007-1429-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  28 in total

1.  Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion.

Authors:  Filip Ryniers; Christophe Stove; Marc Goethals; Liesbeth Brackenier; Veerle Noë; Marc Bracke; Joël Vandekerckhove; Marc Mareel; Erik Bruyneel
Journal:  Biol Chem       Date:  2002-01       Impact factor: 3.915

2.  Expression and potential role of E-cadherin in pancreatic carcinoma.

Authors:  R J Weinel; K Neumann; O Kisker; A Rosendahl
Journal:  Int J Pancreatol       Date:  1996-02

3.  Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.

Authors:  Shahrokh F Shariat; Kazumasa Matsumoto; Roberto Casella; Weiguo Jian; Seth P Lerner
Journal:  Eur Urol       Date:  2005-03-08       Impact factor: 20.096

4.  Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.

Authors:  T Matsumura; R Makino; K Mitamura
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

5.  High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

Authors:  R M Bremnes; R Veve; E Gabrielson; F R Hirsch; A Baron; L Bemis; R M Gemmill; H A Drabkin; W A Franklin
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

6.  E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Authors:  R R Byrne; S F Shariat; R Brown; M W Kattan; J R Morton RA; T M Wheeler; S P Lerner
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

7.  Molecular correlates of gefitinib responsiveness in human bladder cancer cells.

Authors:  Marissa Shrader; Maria Simona Pino; Gordon Brown; Peter Black; Liana Adam; Menahse Bar-Eli; Colin P N Dinney; David J McConkey
Journal:  Mol Cancer Ther       Date:  2007-01       Impact factor: 6.261

8.  Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.

Authors:  Xi-Jiang Zhao; Hui Li; Hua Chen; Yan-Xue Liu; Li-Hua Zhang; Su-Xiang Liu; Qing-Lai Feng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

Authors:  V Noë; B Fingleton; K Jacobs; H C Crawford; S Vermeulen; W Steelant; E Bruyneel; L M Matrisian; M Mareel
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  Soluble E-cadherin fragments increased in circulation of cancer patients.

Authors:  M Katayama; S Hirai; K Kamihagi; K Nakagawa; M Yasumoto; I Kato
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  2 in total

1.  [Plasma E-cadherin levels in urinary bladder cancer: does it improve risk stratification?].

Authors:  T Szarvas; F Hoffmann; M Becker; M Schenck; F Vom Dorp; H Rübben; T Jäger
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

2.  [Siliconchiptechnology-based MMP-7 analysis in urine: an option for preoperative identification of lymph node metastasis in bladder cancer].

Authors:  T Jäger; S Tschirdewahn; F Vom Dorp; G Piechotta; H Rübben; T Szarvas
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.